India, April 6 -- Semaglutide, a GLP-1 receptor agonist commonly used to treat type 2 diabetes and support weight loss, is now being rolled out by England's National Health Service (NHS) as a ...

If you've been following the weight-loss medication revolution, you've likely heard about Wegovy injections. But now there's ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Once opened, compounded semaglutide typically lasts 28 days ...

Weight-loss drugs like Ozempic are becoming increasingly popular in India, but experts warn that misuse without medical ...

Hyderabad: Pharma player Hetero on Friday said it has rolled out exports of its generic semaglutide injection portfolio as ...

FAT jabs have taken over the nation, with 2.5million Brits estimated to be using them and dozens of celebrities showcasing ...

Alongside the rebrand, Terrestrial is planning to establish a new headquarters and manufacturing facility in Boston.

By Dr. Graham A. Colditz Siteman Cancer Center As many of us know, keeping weight in check can be hard. And national numbers ...

Apotex Corp. today announced it has received the first U.S. Food and Drug Administration (FDA) Tentative Approval for its Abbreviated New Drug Application (ANDA) for Semaglutide Injection, marking a ...

Feb 25 - Zydus Lifesciences (ZYDU.NS), opens new tab will launch generic versions of semaglutide injections for obesity and diabetes in India after patent expiry of the Ozempic active ingredient in ...

Tirzepatide vs. semaglutide, which is better? Medical experts agree that tirzepatide has better results, but the right drug ...

Compared with placebo, semaglutide lowered risks for adverse kidney outcomes and mortality across the chronic kidney disease spectrum, according to study data published in Clinical Journal of the ...